|
|
Dr. Dorothy Hayden, a pathologist with Roche Diagnostics, provides a guided digital review of non-small cell lung carcinoma (NSCLC) specimens stained with the Ventana PD-L1 (SP263) Assay. This is…
Content Declaration
Keep for 3 Years COREMAP Content classification C4
No Language (In English)
english
|
|
|
Dr. Dorothy Hayden, a pathologist with Roche Diagnostics, provides instruction on evaluating the Ventana PD-L1 (SP263) assay in non-small cell lung carcinoma (NSCLC) cases. This is part 2 of a 3…
Content Declaration
Keep for 3 Years COREMAP Content classification C4
No Language (In English)
english
|
|
|
Dr. Dorothy Hayden, a pathologist with Roche Diagnostics, provides a brief overview of the Ventana PD-L1 (SP263) assay & staining in non-small cell lung carcinoma (NSCLC) specimens. Please note…
Content Declaration
Keep for 3 Years COREMAP Content classification C4
No Language (In English)
English
|
|
|
Join the Roche Medical Affairs team discussing the role of artificial intelligence in clinical decision support. This workshop previously presented at USCAP 2021. Veeva MC-US-08974
Content Declaration
Keep for 3 Years COREMAP Content classification C4
No Language (In English)
English
|
|
|
Review of FDA classification of IVD assays, overview of clinical trial process as well as IVD development including analytical validation. TE-US-01092
Content Declaration
Keep for 3 Years Language (In English)
English
|
|
|
Review of preanalytic variables in immunohistochemical assay staining. TE-US-01089
Content Declaration
Keep for 3 Years Language (In English)
English
|
|
|
Validation approach for low prevalence biomarkers and biomarkers in rare diseases for IHC assays. TE-US-01072
Content Declaration
Keep for 3 Years Language (In English)
English
|
|
|
Short video on implementing IHC assays in the anatomic pathology laboratory. TE-US-01071
Content Declaration
Keep for 3 Years Language (In English)
English
|
|
|
An overview of validation and verification of IHC in vitro diagnostic assays. TE-US-00990
Content Declaration
Keep for 3 Years Language (In English)
English
|
|
|
Dr. Bharathi Vennapusa reviews CAP/ASCO 2020 guideline update for ER/PgR testing in breast cancer and how these guidelines pertain to Roche ER/PgR assays.
Content Declaration
Keep for 3 Years Language (In English)
English
|
|
|
Dr. Lupe Manriquez from Roche Diagnostics MSA discusses SP263 immune cell scoring. This is part 3 of a 3 part series. Veeva TE-US-01059
Content Declaration
Keep for 3 Years COREMAP Content classification C4
No. Language (In English)
English
|
|
|
Dr. Lupe Manriquez from the Roche Medical and Scientific Affairs team discusses immune cell scoring utilizing the SP263 assay. This is part 2 of a 3 part series. Veeva TE-US-01057
Content Declaration
Keep for 3 Years COREMAP Content classification C4
No. Language (In English)
English
|
|
|
Dr. Lupe Manriquez from the Roche Medical and Scientific Affairs team discusses immune cell scoring utilizing the SP263 assay. This is part 1 of a 3 part series Veeva #TE-US-01058
Content Declaration
Keep for 3 Years COREMAP Content classification C4
No. Language (In English)
English
|
|
|
Dr. Beatrice Wegrzyniak from the Roche Diagnostics US Medical and Scientific Affairs team provides an overview of the new Ventana HER2 Dual ISH assay, comparison to the original assay and examples of…
Content Declaration
Keep for 3 Years COREMAP Content classification C4
No. Language (In English)
English
|
|
|
Dr. Beatrice Wegrzyniak of Roche medical and scientific affairs provides an overview of interpretation of the CINtec PLUS Cytology Assay for cervical cancer triage. Part 4 of a 4 part series. …
Content Declaration
Keep for 3 Years Language (In English)
English
|
|
|
Dr. Beatrice Wegrzyniak of Roche medical and scientific affairs team discusses the biomarkers that indicate cell cycle deregulation in cervical cancer screening. Part 3 of a 4 part series. Content…
Content Declaration
Keep for 3 Years Language (In English)
English
|